ENDOCRINE NEOPLASM

This adverse event was reported 66 times

These drugs are most commonly taken by patients reporting ENDOCRINE NEOPLASM:

# Drug Count
0 ADALIMUMAB 7
1 OCTREOTIDE ACETATE 6
2 EVEROLIMUS 4
3 OMEPRAZOLE 3
4 OMEPRAZOLE MAGNESIUM 3
5 VEDOLIZUMAB 3
6 ALBUTEROL SULFATE 2
7 ATENOLOL 2
8 BEVACIZUMAB 2
9 BORTEZOMIB 2
See all common drugs associated with ENDOCRINE NEOPLASM

ENDOCRINE NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CHLOROTHIAZIDE SODIUM 1 0.0011
1 CHLOROTHIAZIDE 1 0.0008
2 ECALLANTIDE 1 0.0005
3 ALPROSTADIL 1 0.0003
4 OCTREOTIDE ACETATE 6 0.0002
5 CALCIUM CARBONATE, SIMETHICONE 1 0.0002
6 NORETHINDRONE 1 0.0002
7 BENAZEPRIL HYDROCHLORIDE 1 0.0001
8 REPAGLINIDE 1 0.0001
9 LANREOTIDE ACETATE 1 0.0001
See all drugs enriched for association with ENDOCRINE NEOPLASM

ENDOCRINE NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Plasma Kallikrein Inhibitor [EPC] 1 0.0004
1 Glinide [EPC] 1 0.0001
2 Aluminum Complex [EPC] 1 0.0000
3 Integrin Receptor Antagonist [EPC] 3 0.0000
4 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
5 Folate Analog [EPC] 1 0.0000
6 Vitamin A [EPC] 1 0.0000
7 Proteasome Inhibitor [EPC] 2 0.0000
8 Nicotinic Acid [EPC] 1 0.0000
9 Antidote [EPC] 1 0.0000
See all drug classes enriched for association with ENDOCRINE NEOPLASM